- Home
- TLPH vs CWD Comparison
TLPH vs CWD Comparison
Compare TLPH & CWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLPH
- CWD
- Stock Information
- Founded
- TLPH 2005
- CWD 2009
- Country
- TLPH United States
- CWD United States
- Employees
- TLPH N/A
- CWD N/A
- Industry
- TLPH Biotechnology: Pharmaceutical Preparations
- CWD Real Estate
- Sector
- TLPH Health Care
- CWD Finance
- Exchange
- TLPH Nasdaq
- CWD Nasdaq
- Market Cap
- TLPH 12.7M
- CWD 12.1M
- IPO Year
- TLPH 2011
- CWD 2023
- Fundamental
- Price
- TLPH $0.54
- CWD $0.63
- Analyst Decision
- TLPH Strong Buy
- CWD
- Analyst Count
- TLPH 2
- CWD 0
- Target Price
- TLPH $4.50
- CWD N/A
- AVG Volume (30 Days)
- TLPH 122.4K
- CWD 71.1K
- Earning Date
- TLPH 11-13-2024
- CWD 11-12-2024
- Dividend Yield
- TLPH N/A
- CWD N/A
- EPS Growth
- TLPH N/A
- CWD N/A
- EPS
- TLPH N/A
- CWD N/A
- Revenue
- TLPH $281,000.00
- CWD $66,376,999.00
- Revenue This Year
- TLPH N/A
- CWD N/A
- Revenue Next Year
- TLPH N/A
- CWD $38.91
- P/E Ratio
- TLPH N/A
- CWD N/A
- Revenue Growth
- TLPH N/A
- CWD N/A
- 52 Week Low
- TLPH $0.50
- CWD $0.37
- 52 Week High
- TLPH $1.61
- CWD $1.48
- Technical
- Relative Strength Index (RSI)
- TLPH 32.34
- CWD 62.75
- Support Level
- TLPH $0.50
- CWD $0.44
- Resistance Level
- TLPH $0.69
- CWD $0.63
- Average True Range (ATR)
- TLPH 0.05
- CWD 0.04
- MACD
- TLPH -0.01
- CWD 0.01
- Stochastic Oscillator
- TLPH 7.77
- CWD 69.07
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm, whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. Majority of revenue is derived from Asset management fees segment.